Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05280522 · ClinicalTrials.gov registry record
Pain Inhibition With Neuromuscular Electrical Stimulation
A clinical trial, sponsored by University of New England.
- Completed
- Registry status
- 20
- Enrollment target
NCT05280522: Completed study, sponsored by University of New England.
NCT05280522 is a clinical trial that has completed, run by University of New England. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05280522 has completed, sponsored by University of New England.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the pain relieving effect of neuromuscular electrical stimulation that is applied for the purpose of increasing muscle force output.
Primary Outcome
Pain inhibition will be assessed as the difference in pressure pain threshold (PPT) before and 15 minutes after each condition. PPT will be measured with a pain pressure algometer (Algomed, Medco, Durham, NC). Pressure will be applied over the quadriceps tendon 1 cm proximal to the patella through a 1.0 cm diameter tip at a rate of 30 kilopascals/second. Using a standard script, participants are asked to indicate when the sensation changes from deep pressure to pain. PPTs will be measured at the
Interventions
- DEVICE Neuromuscular Electrical Stimulation (NMES)
- OTHER Volitional Contractions (VOL)
- DEVICE Noxious Electrical Stimulation (NXES)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-10-19 |
| Est. Completion | 2019-05-28 |
What the finished NCT05280522 record still lists
NCT05280522 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Neuromuscular Electrical Stimulation (NMES) is the first listed.
NCT05280522 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05280522 about?
NCT05280522 is a clinical study titled "Pain Inhibition With Neuromuscular Electrical Stimulation". The purpose of this study is to demonstrate the pain relieving effect of neuromuscular electrical stimulation that is applied for the purpose of increasing muscle force output.
What is the current status of trial NCT05280522?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2018-10-19. Estimated completion is 2019-05-28.
What interventions are being tested in trial NCT05280522?
The interventions under investigation include: Neuromuscular Electrical Stimulation (NMES) (DEVICE), Volitional Contractions (VOL) (OTHER), Noxious Electrical Stimulation (NXES) (DEVICE).
Who is sponsoring clinical trial NCT05280522?
This trial is sponsored by University of New England, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI